Your session is about to expire
← Back to Search
Tetracycline Antibiotic
2% Doxycycline Cream in Generic Aquaphor for Hives
Phase 2
Waitlist Available
Led By Rauno O Joks, MD
Research Sponsored by State University of New York - Downstate Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
* Adult (ages 18-75) outpatients with diagnosis of allergic rhino-conjunctivitis and/or asthma who have previously undergone epicutaneous skin prick testing with detection of at least one allergen positive, and who may or may not have had a serum IgE level done as part of their routine evaluation.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 60 minutes
Awards & highlights
Summary
Investigators will study the effects of topical doxycycline on cutaneous allergic early and late phase responses by determining allergen skin responses in each subject after a single application to allergen induced allergic swelling of 2% doxycycline in emollient.
Eligible Conditions
- Hives
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 60 minutes
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~60 minutes
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Mean Allergen Induced Wheal Diameter
Trial Design
2Treatment groups
Active Control
Placebo Group
Group I: 2% Doxycycline Cream in Generic AquaphorActive Control1 Intervention
2% Doxycycline Cream in Generic Aquaphor will be applied topically twice during the study visit: first for 30 minutes, then for 6 hours duration. Will perform concurrent to Placebo Comparator
Group II: Generic AquaphorPlacebo Group1 Intervention
Generic Aquaphor will be applied topically twice during the study visit: first for 30 minutes, then for 6 hours duration. Will perform concurrent to Active Comparator.
Find a Location
Who is running the clinical trial?
State University of New York - Downstate Medical CenterLead Sponsor
66 Previous Clinical Trials
12,132 Total Patients Enrolled
Rauno O Joks, MDPrincipal InvestigatorState University of New York - Downstate Medical Center
Share this study with friends
Copy Link
Messenger